Your account is not claimed yet. You can sign up with ORCID to claim your account.

C Richter King

Publication Activity (10 Years)

Years Active: 2019-2022
Publications (10 Years): 3

Top Topics

Randomized Controlled Trial

Transcription Factor

Top Venues

Nature communications

PATH

This page only lists publications with an associated author ORCID identifier.

Affiliation History

PATH May 19o 2014

United States

Director R&D :: CVIA MVI

Publications

Nathan Beutler, Tossapol Pholcharee, David Oyen, Yevel Flores-Garcia, Randall S MacGill, Elijah Garcia, Jaeson Santos Calla-Choque, Mara Parren, Linlin Yang, Wayne Volkmuth, Emily Locke, Jason A Regules, Sheetij Dutta, Daniel Emerling, Angela M Early, Daniel E Neafsey, Elizabeth A Winzeler, C Richter King, Fidel Zavala, Dennis R Burton, Ian A Wilson, Thomas F Rogers
A novel CSP C-terminal epitope targeted by an antibody with protective activity against Plasmodium falciparum. PLoS pathogens 18 (3) (2022)
Tossapol Pholcharee, David Oyen, Yevel Flores-Garcia, Gonzalo E González-Páez, Zhen Han, Katherine L Williams, Wayne Volkmuth, Daniel Emerling, Emily Locke, C Richter King, Fidel Zavala, Ian A Wilson
Structural and biophysical correlation of anti-NANP antibodies with in vivo protection against P. falciparum. Nature communications 12 (1) (2021)
Brandon McLeod, Kazutoyo Miura, Stephen W Scally, Alexandre Bosch, Ngan Nguyen, Hanjun Shin, Dongkyoon Kim, Wayne Volkmuth, Sebastian Rämisch, Jessica A Chichester, Stephen Streatfield, Colleen Woods, William R Schief, Daniel Emerling, C Richter King, Jean-Philippe Julien
Potent antibody lineage against malaria transmission elicited by human vaccination with Pfs25. Nature communications 10 (1) (2019)